Inventor
PARSY CHRISTOPHE CLAUDE
FR21 patents
⚠️ This page may combine multiple inventors who share the name “PARSY CHRISTOPHE CLAUDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDENIX PHARMACEUTICALS INC
12 patentsUS9109001B2Aug 18, 2015
3′,5′-cyclic phosphoramidate prodrugs for HCV infection
IDENIX PHARMACEUTICALS INC60 citations97
US8507460B2Aug 13, 2013
Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
IDENIX PHARMACEUTICALS INC67 citations97
US8362068B2Jan 29, 2013
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
IDENIX PHARMACEUTICALS INC66 citations96
US9309275B2Apr 12, 2016
3′-deoxy nucleosides for the treatment of HCV
IDENIX PHARMACEUTICALS INC28 citations93
US9296778B2Mar 29, 2016
3′,5′-cyclic phosphate prodrugs for HCV infection
IDENIX PHARMACEUTICALS INC37 citations93
US9187496B2Nov 17, 2015
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
IDENIX PHARMACEUTICALS INC8 citations82
US8993595B2Mar 31, 2015
Macrocyclic serine protease inhibitors
IDENIX PHARMACEUTICALS INC8 citations82
US8377962B2Feb 19, 2013
Macrocyclic serine protease inhibitors
IDENIX PHARMACEUTICALS INC14 citations82
US8481748B2Jul 9, 2013
Phosphinate ruthenium complexes
IDENIX PHARMACEUTICALS INC4 citations73
US8765966B2Jul 1, 2014
Phosphinate ruthenium complexes
IDENIX PHARMACEUTICALS INC2 citations62
US8410313B2Apr 2, 2013
Phosphinate ruthenium complexes
IDENIX PHARMACEUTICALS INC1 citations62
US9115095B2Aug 25, 2015
Phosphinate ruthenium complexes
IDENIX PHARMACEUTICALS INC0 citations51
PARSY CHRISTOPHE CLAUDE
3 patentsUS9353100B2May 31, 2016
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
PARSY CHRISTOPHE CLAUDE8 citations82
US9284307B2Mar 15, 2016
Macrocyclic serine protease inhibitors
PARSY CHRISTOPHE CLAUDE8 citations82
US8309737B2Nov 13, 2012
Phosphinate ruthenium complexes
PARSY CHRISTOPHE CLAUDE4 citations71
IDENIX PHARMACEUTICALS LLC
3 patentsUS10030044B2Jul 24, 2018
Nucleotides for the treatment of liver cancer
IDENIX PHARMACEUTICALS LLC4 citations72
US10766917B2Sep 8, 2020
Nucleotides for the treatment of cancer
IDENIX PHARMACEUTICALS LLC1 citations62
US10513534B2Dec 24, 2019
2′-chloro nucleoside analogs for HCV infection
IDENIX PHARMACEUTICALS LLC0 citations50